Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MS
MS
Biogen MS drug scripts up 12% in week eight, says Citigroup
The Fly on the Wall
Mon, 06/3/13 - 12:40 pm
MS
Biogen Idec
multiple sclerosis
Tecfidera
FDA Accepts Teva sNDA - Analyst Blog
NASDAQ
Sat, 06/1/13 - 01:09 pm
Teva Pharmaceuticals
Copaxone
multiple sclerosis
MS
Biogen’s MS Pill Delayed in Europe as Patent Extended
Bloomberg
Thu, 05/30/13 - 11:34 am
Biogen Idec
Europe
patents
MS
multiple sclerosis
Tecfidera
Biogen Idec's MS Drug Launch Is Going Amazingly Well. These Two Graphs Prove It
Forbes
Wed, 05/29/13 - 04:31 pm
drug launches
MS
multiple sclerosis
Biogen Idec
Tecfidera
Biogen Idec submits Plegridy to FDA for multiple sclerosis patients with relapsed disease
Yahoo/AP
Wed, 05/22/13 - 09:43 am
Biogen Idec
MS
multiple sclerosis
FDA
Plegridy
XenoPort Sinks as Spasticity Drug For MS Fails in Trial
Bloomberg
Mon, 05/20/13 - 11:36 am
XenoPort
MS
multiple sclerosis
arbaclofen placarbil
The Biogen MS Pill: The 'Holy Mother' Of All Drug Launches?
Pharmalot
Mon, 04/29/13 - 11:40 am
Biogen Idec
Tecfidera
drug launches
MS
multiple sclerosis
Biogen MS Pill’s Early Sales May Help It Beat Estimates
Bloomberg
Mon, 04/29/13 - 10:52 am
MS
multiple sclerosis
Biogen Idec
BG-12
Tecfidera
Biogen's MS Pill Roars Out Of Launch Gate
TheStreet.com
Mon, 04/22/13 - 10:52 am
Biogen
drug launches
MS
multiple sclerosis
Tecfidera
Gilenya
Novartis
Biogen Hits Primary Endpoints in MS Study
Motley Fool
Sat, 04/6/13 - 10:53 am
Biogen
MS
multiple sclerosis
daclizumab
Biogen Idec up after positive MS drug study
Marketwatch
Thu, 04/4/13 - 01:54 pm
Biogen Idec
MS
multiple sclerosis
AbbVie
daclizumab
Elan completes sale of Tysabri stake to Biogen
Reuters
Wed, 04/3/13 - 10:51 am
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis
Tecfidera Raises The Bar For Biogen Idec
Seeking Alpha
Tue, 04/2/13 - 09:48 am
MS
multiple sclerosis
Biogen Idec
Tecfidera
Novartis
Sanofi
Biogen prices new MS drug at discount to key competitors
Reuters
Sat, 03/30/13 - 10:37 am
Biogen
Tecfidera
multiple sclerosis
MS
Biogen Reveals Pricing For New MS Drug Tecfidera
Forbes
Fri, 03/29/13 - 11:17 am
Biogen
MS
multiple sclerosis
Tecfidera
Biogen Wins FDA Approval of MS Pill
TheStreet.com
Thu, 03/28/13 - 08:45 am
Biogen Idec
FDA
MS
BG-12
multiple sclerosis
Tecfidera
Biogen And The Progress In Multiple Sclerosis Treatment
Seeking Alpha
Tue, 03/26/13 - 10:26 am
MS
multiple sclerosis
Biogen Idec
Tecfidera
BG-12
Aubagio EU Backing Comes With Generic Worries
Seeking Alpha
Tue, 03/26/13 - 09:33 am
Aubagio
Europe
generics
Sanofi
MS
multiple sclerosis
Sanofi’s Lemtrada MS Drug Effective in Extension Trial
Bloomberg
Fri, 03/22/13 - 10:55 am
Sanofi
Lemtrada
MS
multiple sclerosis
Biogen’s MS Pill Gains 8 More Years of Patent Protection
Bloomberg
Wed, 03/20/13 - 12:12 pm
MS
multiple sclerosis
patents
Biogen Idec
Tecfidera
Pages
« first
‹ previous
…
18
19
20
21
22
23
24
25
26
…
next ›
last »